Dream on @antibotter ... there is nothing exciting in that quarterly IMO ....... and look at this wording :
Receipts from customers for the quarter totalled $1.1 million, which includes launch/regulatory milestones, product supply and royalty receipts from partners for VivaGel® BV.
The market is never told what these milestone payments for Vivagel are ($ wise) so we have no idea if the product is actually selling well or if the majority of this $1.132m is made up of 'launch/regulatory milestone' amounts ? $1m for all we know could be just for milestones and so that would leave very little profits from Vivagel sales if that were the case ?
On the topic of Fluerstat - I welcome you to find me some reviews ? Very few on the internet that I can see ? .....if it was a block buster product I would expect reviews everywhere (I don't do FB so I cannot comment on the social media aspect) but others here claimed to have been part of the FB group on BV and I don't even see them posting feedback from that group anymore about Vivagel !!
.... oh and I have read the report - twice it was that short .... and again "nothing exciting" in it IMO - certainly nothing to make me want to vote yes to the remuneration - just sayin'
SPL Price at posting:
$1.15 Sentiment: Hold Disclosure: Held
